Abstract
Modulation by NO of systolic myocardial function received widespread attention but most studies focused on potential negative inotropic properties of NO. The very original observations on the effects of NO on myocardial contraction already provided evidence that NO modified myocardial contractile performance mainly through a relaxation-hastening effect (i.e. earlier onset of relaxation) and through an increase in myocardial distensibility. The present review discusses the relaxation hastening and distensibility-increasing effects of NO in experimental preparations, in the normal human heart, in left ventricular hypertrophy of aortic stenosis, in the human allograft and in dilated nonischemic cardiomyopathy. This 'diastolic flip side' of the myocardial effects of NO appears to be beneficial especially for patients who are dependent on the LV Frank-Starling response to maintain cardiac output.
Similar content being viewed by others
References
Lewis MJ, Shah AM. Endothelial modulation of cardiac function. Harwood Academic Publishers, Amsterdam 1997.
Kelly RA, Han X. Nitrovasodilators have (small) direct effects on cardiac contractility. Is this important? Circulation 1997;96:2493–2495.
Smith JA, Shah AM, Lewis MJ. Factors released from endothelium of the ferret and pig modulate myocardial contraction. Journal of Physiology (London) 1991;439:1–14.
Meulemans AL, Sipido KR, Sys SU, Brutsaert DL. Atriopeptin III induces early relaxation of isolated mammalian papillary muscle. Circ Res 1988;62:1171–1174.
Shah AM, Spurgeon HA, Sollott SJ, Talo A, Lakatta EG. 8-Bromo-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes. Circ Res 1994;74:970–978.
Paulus WJ, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Circulation 1994;89:2070–2078.
Mohan P, Brutsaert DL, Paulus WJ, Sys SU. Myocardial contractile response to nitric oxide and cGMP. 1996;93:1223–1229.
Grocott-Mason R, Fort S, Lewis MJ, Shah AM. Myocardial relaxant effect of exogenous nitric oxide in the isolated ejecting heart. Am J Physiol 1994;266:H1699–H1705.
Grocott-Mason R, Anning P, Evans H, Lewis MJ, Shah AM. Modulation of left ventricular relaxation in the isolated ejecting heart by endogenous nitric oxide. Am J Physiol 1994;267:H1804–H1813.
Anning PB, Grocott-Mason R, Lewis MJ, Shah AM. Enhancement of left ventricular relaxation in the isolated rat heart by an angiotensin-converting enzyme inhibitor. Circulation 1995;92:2660–2665.
Ito N, Bartunek J, Spitzer KW, Lorell BH. Effects of the nitric oxide donor sodium nitroprusside on intercellular pH and contraction in hypertrophied myocytes. Circulation 1997;95:2303–2311.
Ito N, Kagaya Y, Weinberg EO, Barry WH, Lorell BH. Differing effects of endothelin on contraction, intracellular pH and intracellular Ca2+ in hypertrophied and normal rat myocytes. J Clin Invest 1997;99:125–135.
Cingolani HE, Alvarez BV, Ennis IL, Camilion de Hurtado MC. Stretch-induced alkalinization of feline papillary muscle: an autocrine-paracrine system. Circ Res 1998;33:775–780.
Lew WYW, Ryan J, Yasuda S. Lipopolysaccharide induces cell shrinkage in rabbit ventricular cardiac myocytes. Am J Physiol 1997;272:H2989–H2993.
Clemo HF and Baumgarten CM. cGMP and atrial natriuretic factor regulate cell volume of rabbit atrial myocytes. Circ Res 1995;77:741–749.
Prendergast BD, Sagach VF, Shah AM. Basal release of nitric oxide augments the Frank-Starling response in the isolated heart. Circulation 1997;96:1320–1329.
Sagach VF, Shimanskaya TV, Sagach VV, Bogomolets AA. Coronary endothelium dysfunction and heart failure. The Journal of Heart Failure 1998;5:79(Abstr.)
Pinsky DJ, Patton S, Mesaros S, Brovkovych V, Kubaszewski E, Grunfeld S, Malinski T. Mechanical transduction of nitric oxide synthesis in the beating heart. Circ Res 1997;81:372–379.
Matsubara BB, Matsubara LS, Zornoff AM, Franco M, Janicki JS. Left ventricular adaptation to chronic pressure overload induced by inhibition of nitric oxide synthase in rats. Basic Res Cardiol 1998;93:173–181.
Pagani FD, Baker LS, Hsi C, Knox M, Fink MP, Visner MS. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-? in conscious dogs. J Clin Invest 1992;90:389–398.
Murray DR, Freeman GL. Tumor necrosis factor-a induces a biphasic effect on myocardial contractility in conscious dogs. Circ Res 1996;78:154–160.
Panas D, Khadour FH, Szabo C, Schulz R. Proinflammatory cytokines depress cardiac efficiency by a nitric-oxide dependent mechanism. Am J Physiol 1998;275:H1016–H1025.
Carroll JD, Lang RM, Neumann AL, Borow KM, Rajfer SI. The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy. Circulation 1986;74:815–825.
Kingma L, Smiseth OA, Belenkie I, Knudtson ML, Mc Donald RPR, Tyberg JV. A mechanism for the nitroglycerin-induced downward shift of the left ventricular diastolic pressure-diameter relationship of patients. Am J Cardiol 1986;57:673–677.
Krogmann ON, Rammos S, Jakob M, Corin WJ, Hess OM, Bourgeois M. Left ventricular diastolic function late after coarctation repair in childhood: influence of left ventricular hypertrophy. J Am Coll Cardiol 1993;21:1454–1461.
Paulus WJ, Vantrimpont PJ, Shah AM. Paracrine coronary endothelial control of left ventricular function in humans. Circulation 1995;92:2119–2126.
Matter CM, Mandinov L, Kaufmann PA, Vassalli G, Jiang Z, Hess OM. Effects of NO-donors on LV diastolic function in patients with severe pressure-overload hypertrophy. Circulation 1999;99:2396–2401.
McCarthy P. Impaired endothelium-dependent regulation of ventricular relaxation in pressure-overload cardiac hypertrophy. Circulation 2000;101:1854–1860.
Paulus WJ. Nitric oxide and cardiac contraction:clinical studies. In:`Endothelial modulation of cardiac function'edited by MJ Lewis and AM Shah, Harwood academic publishers, Amsterdam, 1997;35–51.
Paulus WJ, Bronzwaer JGF, Felice H, Kishan N, Wellens F. Deficient acceleration of left ventricular relaxation during exercise after heart transplantation. Circulation 1992;86:1175–1185.
Bartunek J, Shah AM, Vanderheyden M, Paulus WJ. Dobutamine enhances cardiodepressant effects of receptor-mediated coronary endothelial stimulation. Circulation 1997;95:90–96.
Paulus WJ, Kästner S, Pujadas P, Shah AM, Drexler H, Vanderheyden M. Left ventricular contractile effects of inducible nitric oxide synthase in the human allograft. Circulation 1997;96:3436–3442.
Fukuchi M, Hussain SNA, Giaid A. Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure. Their relation to lesion site and ?-adrenergic receptor therapy. Circulation 1998;98:132–139.
Stein B, Eschenhagen T, Rüdiger J, Scholz H, Förstermann U, Gath I. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure. J Am Coll Cardiol 1998;32:1179–1186.
Haywood GA, Tsao PS, von der Leyen HE et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation 1996;93:1087–1094.
Drexler H, Kästner S, Strobel A, Studer R, Brodde OE, Hasenfuss G. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. J Am Coll Cardiol 1998;32:955–963.
Heymes C, Vanderheyden M, Bronzwaer JGF, Shah AM, Paulus WJ. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. Circulation 1999;99:3009–3016.
Paulus WJ, Shah AM. NO and cardiac diastolic function. Cardiovascular Research 1999;43:595–606.
Zeitz CJ, Heymes C, Paulus WJ. Increased endomyocardial cNOS expression improves diastolic compliance in human dilated cardiomyopathy. Circulation 1999;100:I–78 (Abstr)
Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL. Tumor necrosis factor a and tumor necrosis factor receptors in the failing human heart. Circulation 1996;93:704–711.
Satoh M, Nakamura M, Tamura G et al. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy. J Am Coll Cardiol 1997;29:716–724.
Ferrari R, Bachetti T, Confortini R et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995;92:1479–1486.
Singh K, Balligand JL, Fischer TA, Smith TW, Kelly RA. Glucocorticoids increase osteopontin expression in cardiac myocytes and microvascular endothelial cells:role in regulation of inducible nitric oxide synthase. J Biol Chem 1995;270:28471–28478.
Wang J, Wolin MS, Hintze TH. Chronic exercise enhances endothelium-mediated dilation of epicardial coronary artery in conscious dogs. Circ Res 1993;73:829–838.
Hintze TH, Wang J, Omar HA, Wolin MS. Enhanced large coronary artery dilation in conscious dogs and relaxation in vitro after chronic pacing-induced increased coronary blood flow velocity. Circulation 1989;80:II–279 (Abstr.)
European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure? European Heart Journal 1998;19:990–1003.
Hare JM, Walford GD, Hruban RH, Hutchins GM, Deckers JW, Baugham KL. Ischemic cardiomyopathy: endomyocardial biopsy and ventriculographic evaluation of patients with congestive heart failure, dilated cardiomyopathy and coronary artery disease. J Am Coll Cardiol 1992;20:1318–1325.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Paulus, W.J. Beneficial Effects of Nitric Oxide on Cardiac Diastolic Function: 'The Flip Side of the Coin'. Heart Fail Rev 5, 337–344 (2000). https://doi.org/10.1023/A:1026511229882
Issue Date:
DOI: https://doi.org/10.1023/A:1026511229882